Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation

Free Radical Research

Volumn 37, Issue 1, 2003, Pages 33-40

  Coppey, Lawrence J ^a   Gellett, Jill S ^a   Davidson, Eric P ^a   Yorek, Mark A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Diabetes; Oxidative stress; Protein kinase C; Superoxide; Vascular reactivity

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ACETYLCHOLINE; ALLOPURINOL; AMINOGUANIDINE; ARGININE; BISINDOLYLMALEIMIDE; DIHYDROLIPOATE; PEROXYNITRITE; PROTEIN KINASE C INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ROTENONE; SUPEROXIDE; TEMPOL; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTERIOLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; IN VITRO STUDY; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; RAT; RESPIRATORY CHAIN; REVIEW; SCIATIC NERVE; STREPTOZOCIN DIABETES; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; ARGININE; ARTERIOLES; CYCLIC N-OXIDES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; INDOLES; MALE; MALEIMIDES; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; OXIDATIVE STRESS; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; SPIN LABELS; SUPEROXIDES; THIOCTIC ACID; VASODILATION;

ANIMALIA;

EID: 0037245335     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/1071576021000028442     Document Type: Review

References (37)

1. Cameron, N.E. and Cotter, M.A. (1994) "The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications", Diabetes-Metab. Rev. 10, 189-224.
2. Cameron, N.E., Cotter, M.A. and Low, P.A. (1991) "Nerve blood flow in early experimental diabetes in rats: relation to conduction defects", Am. J. Physiol. 261, E1-E8.
3. Cameron, N.E., Cotter, M.A., Archibald, V., Dines, K.C. and Maxfield, E.K. (1994) "Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats", Diabetologia 37, 449-459.
4. Cohen, R.A. (1993) "Dysfunction of vascular endothelium in diabetes mellitus", Circulation 87, 67-76.
5. Omawari, N., Dewhurst, M., Vo, P., Mahmood, S., Stevens, E. and Tomlinson, D.R. (1996) "Deficient nitric oxide responsible for reduced nerve blood flow in diabetic rats: effects of L-NAME, L-arginine, sodium nitroprusside and evening primrose oil", Br. J. Pharm. 118, 186-190.
6. Pieper, G.M. (1998) "Review of alterations in endothelial nitric oxide production in diabetes", Hypertension 31, 1047-1060.
7. Tomlinson, D.R. (1992) "The pharmacology of diabetic neuropathy", Diabetes-Metab. Rev. 8, 67-84.
8. Ward, J.D. (1995) "Biochemical and vascular factors in the pathogenesis of diabetic neuropathy", Clin. Investig. Med. 18, 267-274.
9. Greene, D.A., De Jesus, P.V. and Winegrad, A.I. (1975) "Effects of insulin and dietary myo-inositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes", J. Clin. Investig. 55, 1326-1336.
10. Kim, J., Kyriazi, H. and Greene, D.A. (1991) "Normalization of Na + -K + -ATPase activity in isolated membrane fraction from sciatic nerves of streptozotocin-induced diabetic rats by dietary myo-inositol supplementation in vivo or protein kinase C agonists in vitro", Diabetes 40, 558-567.
11. Mayer, J.H. and Tomlinson, D.R. (1983) "Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or aldose reductase inhibitor in streptozotocin-diabetic rats", Diabetologia 25, 433-438.
12. Coppey, L.J., Davidson, E.P., Dunlap, J.A., Lund, D.D. and Yorek, M.A. (2000) "Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles; that provide circulation to the sciatic nerve", Int. J. Exp. Diabetes Res. 1, 131-143.
13. Coppey, L.J., Gellett, J.S., Davidson, E.P., Dunlap, J.A., Lund, D.D. and Yorek, M.A. (2001) "Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve", Diabetes 50, 1927-1937.
14. Coppey, L.J., Gellett, J.S., Davidson, E.P., Dunlap, J.A., Lund, D.D., Salvemini, D. and Yorek, M.A. (2001) "Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular function of epineurial arterioles; of the sciatic nerve", Br. J. Pharm. 134, 121-129.
15. Nishikawa, T., Edelstein, D., Du, X.L., Yamagishi, S., Matsumura, T., Kaneda, Y, Yorek, M.A., Beebe, D., Oates, P.J., Hammes, H.P., Giardino, I. and Brownlee, M. (2000) "Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage", Nature 404, 787-790.
16. Brownlee, M. (2001) "Biochemistry and molecular cell biology of diabetic complications", Nature 414, 813-820.
17. Terata, K., Coppey, L.J., Davidson, E.P., Dunlap, J.A., Gutterman, D.D. and Yorek, M.A. (1999) "Acetylcholine-induced arteriolar dilation is reduced in streptozotocin induced diabetic rats with motor nerve dysfunction", Br. J. Pharm. 128, 837-843.
18. Coleman, M.D., Eason, R.C. and Bailey, C.J. (2001) "The therapeutic use of lipoic acid in diabetes: a current perspective", Environ. Toxicol. Pharmacol. 10, 167-172.
19. Packer, L., Kraemer, K. and Rimbach, G. (2001) "Molecular aspects of lipoic acid in the prevention of diabetes complications", Nutrition 17, 888-895.
20. Schnackenberg, C.G. and Wilcox, C.S. (2001) "The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes", Kidney Int. 59, 1859-1864.
21. Nassar, T., Kadery, B., Lotan, C., Da'as, N., Kleinman, Y. and Haj-Yehia, A. (2002) "Effects of the superoxide dismutase-mimetic compound tempol on endothelial dysfunction in streptozotocin-induced diabetic rats", Eur. J. Pharm. 436, 111-118.
22. Pieper, G.M. and Peltier, B.A. (1995) "Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium", J. Cardiovasc. Pharm. 25, 397-403.
23. Pieper, G.A., Siebeneich, W. and Dondlinger, L.A. (1996) "Short-term oral administration of L-arginine reverses defective endothelium-dependent relaxation and cGMP generation in diabetes", Eur. J. Pharm. 317, 317-320.
24. Giugliano, D., Marfella, R., Verrazzo, G., Acampora, R., Coppola, L., Cozzolino, D. and D'Onofrio, F. (1997) "The vascular effects Of L-arginine in humans", J. Clin. Investig. 99, 433-438.
25. Giugliano, D., Marfella, R., Coppola, L., Verrazzo, G., Acampora, R., Giunta, R., Nappo, F., Lucarelli, C. and D'Onofrio, F. (1997) "Vascular effects of acute hyperglycemia in humans are reversed by L-arginine", Circulation 95, 1783-1790.
26. Yildirim, S., Ayan, S., Sarioglu, Y, Gultekin, Y and Butuner, C. (1999) "The effects of long-term oral administration of L-arginine on the erectile response of rabbits with alloxan-induced diabetes", BJU Int. 83, 679-685.
27. Pieper, G.A. and Dondlinger, L.A. (1997) "Plasma and vascular tissue arginine are decreased in diabetes: acute arginine supplementation restores endothelium-dependent relaxation by augmenting cGMP production", J. Pharm. Exp. Ther. 283, 684-691.
28. Baynes, JW and Thorpe, S.R. (1999) "Role of oxidative stress in diabetic complications", Diabetes 48, 1-9.
29. Cameron, N.E., Cotter, M.A., Archibald, V., Dines, K.C. and Maxfield, E.K. (1994) "Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats", Diabetologia 37, 449-459.
30. Kim, Y.K., Lee, M.S., Son, S.M., Kim, I.J., Lee, W.S., Rhim, B.Y., Hong, K.W., and Kim, C.D. (2002) "Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes", Diabetes 51, 522-527.
31. Li, Y. and Trush, M.A. (1998) "Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production", Biochem. Biophys. Res. Commun. 253, 295-299.
32. Inoguchi, T., Li, P., Umeda, F., Yu, H.Y, Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M., Sano, H., Utsumi, H. and Nawata, H. (2000) "High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells", Diabetes 49, 1939-1945.
33. Meier, M. and King, G.L. (2000) "Protein kinase C activation and its pharmacological inhibition in vascular disease", Vasc. Med. 5, 173-185.
34. Booth, G., Stalker, T.J., Lefer, A.M. and Scalia, R. (2002) "Mechanisms of amelioration of glucose-induced endothelial dysfunction following inhibition of protein kinase C in vivo", Diabetes 51, 1356-1564.
35. Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M., Thaiss, F., Stahl, R.A., Warnholtz, A., Meinertz, T., Griendling, K., Harrison, D.G., Forstermann, U. and Munzel, T. (2001) "Mechanisms underlying endothelial dysfunction in diabetes mellitus", Circ. Res. 88, E14-E22.
36. Desco, M.C., Asensi, M., Marquez, R., Martinez-Valls, J., Vento, M., Pallardo, F.V., Sastre, J. and Vina, J. (2002) "Xanthine oxidase is involved in free radical production in Type I diabetes", Diabetes 51, 1118-1124.
37. Mahar Doan, K.M., Ng, S. and Boje, K.M. (2000) "Cellular transport processes of aminoguanidine, a nitric oxide synthase inhibitor, in the opposum kidney cell culture line", Int. J. Pharma. 194,